Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 732-737

  Shibao, Kazunori ^a   Takano, Hiroshi ^a   Nakayama, Yoshifumi ^a   Okazaki, Keisuke ^a   Nagata, Naoki ^a   Izumi, Hiroto ^a   Uchiumi, Takeshi ^b   Kuwano, Michihiko ^b   Kohno, Kimitoshi ^a   Itoh, Hideaki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING);

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0032707960     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991210)83:6<732::aid-ijc6>3.0.co;2-%23     Document Type: Article

References (22)

1. BARGOU, R.C., JURCHOTT, K., WAGENER, C., BERGMANN, S., METZNER, S., BOMMERT, K., MAPARA, M.Y., WINZER, K.J., DIETER, M., DÜRKEN, B. and ROYER, H.D., Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR-1 gene expression. Nature (Med.), 3, 447-450 (1997).
2. BECK, W.T. AND 24 OTHERS, Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res., 56, 3010-3020 (1996).
3. BRANDT, T.L., FRASER, D.J., LEAL, S., HALANDRAS, P.M., KROLL, A.R. and KROLL, D.J., c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter. J. Biol. Chem., 272, 6278-6284 (1997).
4. ENDICOTT, J.A. and LING, V., The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171 (1989).
5. FURUKAWA, M., UCHIUMI, T., NOMOTO, M., TAKANO, H., MORIMOTO, R., KUWANO, M., and KOHNO, K., The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase II μ gene by heat shock. J. Biol. Chem., 273, 10550-10555 (1998).
6. HECK, M.M., HITTELMAN, W.N. and EARNSHAW, W.C., Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc. Nat. Acad. Sci. (Wash.), 85, 1086-1090 (1988).
7. ISE, T. AND 12 OTHERS, Transcriptional factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res., 59, 342-346 (1999).
8. KOIKE, K., UCHIUMI, T., OHGA, T., TOH, S., WADA, M., KOHNO, K. and KUWANO, M., Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett., 417, 390-394 (1997).
9. KUBO, T., KOHNO, K., OHGA, T., TANIGUCHI, K., KAWANAMI, K., WADA, M. and KUWANO, M., DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells. Cancer Res., 55, 3860-3864 (1995).
10. LADOMERY, M. and SOMMERVILLE, J., A role for Y-box proteins in cell proliferation. Bioessays, 17, 9-11 (1995).
11. LI, R., WAGA, S., HANNON, G.J., BEACH, D. and STILLMAN, B., Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371, 534-537 (1994).
12. ODA, Y., SAKAMOTO, A., SHINOHARA, N., OHGA, T., UCHIUMI, T., KOHNO, K., TSUNEYOSHI, M., KUWANO, M. and IWAMOTO, Y. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin. Cancer Res., 4, 2273-2277 (1998).
13. OHGA, T., KOIKE, K., ONO, M., MAKINO, Y., ITAGAKI, Y., TANIMOTO, M., KUWANO, M. and KOHNO, K., Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res., 56, 4224-4228 (1996).
14. OHGA, T., UCHIUMI, T., MAKINO, Y, KOIKE, K., WADA, M., KUWANO, M. and KOHNO, K., Direct involvement of the Y-box binding protein YB-1 in genomic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem., 273, 5997-6000 (1998).
15. SWANYNATHAN, S.K, NAMBIAR, A. and GUNTAKA, R.V., Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J., 12, 515-522 (1998).
16. TEIXEIRA, C.R., TANAKA, S., HARUMA, K., YOSHIHARA, M., SUMII, K. and KAJIYAMA, G., Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer, 73, 575-579 (1994).
17. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M.M., PASTAN, I. and WILLINGHAM, M.C., Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Nat. Acad. Sci. (Wash.), 84, 7735-7738 (1987).
18. TUCCARI, G., RIZZO, A., GIUFFRE, G. and BARRESI, G., Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features. Virchows Arch. A Pathol. Anat. Histopathol., 423, 51-55 (1993).
19. WAGA, S., HANNON, G.J., BEARCH, D. and STILLMAN, B., The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369, 574-578 (1994).
20. WANG, Q., ZAMBETTI, G.P. and SUTTLE, D.P., Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor. Mol. Cell. Biol., 17, 389-397 (1997).
21. WEINSTEIN, R.S., JAKATE, S.M., DOMINGUEZ, J.M., LEBOVITZ, M.D., KOUKOULIS, G.K., KUSZAK, J.R., KLUSENS, L.F., GROGAN, T.M., SACLARIDES, T.J., RONINSON, I.B. and COON, J.S., Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res., 51, 2720-2726 (1991).
22. YABUKI, N., SASANO, H., KATO, K., OHARA, S., TOYOTA, T., NAGURA, H., MIYAIKE, M., NOZAKI, N. and KIKUCHI, A., Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Amer. J. Pathol., 149, 997-1007 (1996).